FDA Adverse Event Death Summary report: N

V.A.C. ATS

MDR report key: 4417322 · Received January 12, 2015

Report

Report Number
3009897021-2015-00003
Event Type
Death
Date Received
January 12, 2015
Report Date
August 1, 2014
Manufacturer
KCI USA INC.
Product Code
OMP
PMA / PMN Number
K062227
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

IT IS UNK WHEN THE EVENT OCCURRED AS THIS INFO HAS NOT BEEN PROVIDED. BASED ON INFO PROVIDED, IT CANNOT BE DETERMINED THAT THE INFECTION OR PT EXPIRING IS RELATED TO V.A.C. THERAPY.

Description of Event or Problem · 1

EP-2 "A CASE DEVELOPED PROBABLE TOXIC SHOCK SYNDROME UNDER V.A.C. THERAPY" INCLUDED IN THE 3RD ANNUAL MEETING OF (B)(6) SOCIETY FOR SURGICAL WOUND CARE REPORTED THAT A SUSPECTED TOXIC SHOCK SYNDROME WAS OBSERVED AFTER V.A.C. THERAPY, WHICH ALLEGEDLY ENDED IN THE DEATH OF THE PT. THE PT HAD A PARAPLEGIA CAUSED BY MYELITIS TRANSVERSE 30 YEARS AGO AND HAD UNDERWENT SEVERAL SURGERIES FOR SACRAL AND ISCHIAL PRESSURE ULCERS. "AROUND (B)(6) 2010, THE PT'S SACRAL PRESSURE ULCER WORSENED. IN (B)(6), THE PT UNDERWENT A SURGICAL DEBRIDEMENT FOR SKIN NECROSIS AND AN INFECTION. V.A.C. THERAPY WAS APPLIED WHEN THE SIGNS OF INFECTION HAD RESOLVED AND GRANULATION OCCURRED. TEN DAYS AFTER THE APPLICATION OF V.A.C. THERAPY, THE PT EXPERIENCED A FEVER, DECREASED URINE VOLUME, CPK AND HIGHER SERUM CREATININE LEVELS DESPITE A SUCCESSFUL GRANULATION PROCESS. THE PT UNDERWENT A POLYMYXIN IMMUNOADSORPTION AND WAS MOVED TO THE INTENSIVE CARE UNIT. ON THE 12TH DAY, THE PT EXPIRED DUE TO MULTIORGAN FAILURE. (B)(6) WAS OBSERVED BY WOUND INCUBATION, HOWEVER, BLOOD AND THROAT CULTURES WERE NEGATIVE. THE UNIT'S SERIAL NUMBER WAS NOT PROVIDED, THEREFORE, KCI CANNOT CONDUCT A DEVICE EVALUATION OF THE UNIT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
27599 V.A.C. ATS OMP KCI USA INC. WNDATS

Patients

Seq Age Sex Outcome Treatment
1 Death